Ignite Creation Date:
2025-12-25 @ 4:36 AM
Ignite Modification Date:
2025-12-26 @ 3:38 AM
Study NCT ID:
NCT01059318
Status:
COMPLETED
Last Update Posted:
2020-11-19
First Post:
2010-01-28
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
A Study to Determine the Safety and Effectiveness of RAD001 (Everolimus) in Patients With Lymphangioleiomyomatosis
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-01
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-06
Completion Date Type:
ACTUAL
First Submit Date:
2010-01-28
First Submit QC Date:
None
Study First Post Date:
2010-01-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-06-14
Results First Submit QC Date:
None
Results First Post Date:
2020-11-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-11-16
Last Update Post Date:
2020-11-19
Last Update Post Date Type:
ACTUAL